Drug Type Radiolabeled antibody, Diagnostic radiopharmaceuticals |
Synonyms Tc 99m besilesomab, Tc 99m-labeled monoclonal antibody BW 250/183, 99TCM-BW250-183 + [5] |
Target |
Mechanism CEACAM8 inhibitors(Non specific cross-reacting antigen 95 inhibitors), SPECT(Single-photon emission-computed tomography enhancers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date EU (11 Jan 2010), |
RegulationOrphan Drug (EU) |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D10844 | Tc 99m besilesomab |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Osteomyelitis | EU | 11 Jan 2010 | |
Osteomyelitis | IS | 11 Jan 2010 | |
Osteomyelitis | LI | 11 Jan 2010 | |
Osteomyelitis | NO | 11 Jan 2010 |